ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$256.00
−1.62%0
Insider buys (3m)
1
Insider sells (3m)
-$8.2M
Net value (3m)
+13.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Donoghoe Nicholas · officer: EVP, CHIEF BUS/STRAT OFFICER | M-Exempt | 32,710 | $79 |
| Aug 18, 2026 | Donoghoe Nicholas · officer: EVP, CHIEF BUS/STRAT OFFICER | Sale | 32,710 | $250 |
| Jul 2, 2026 | Quaggin Susan E · director | A-Award | 62 | $252 |
| Jul 2, 2026 | RAPP EDWARD J · director | A-Award | 134 | $252 |
| May 12, 2026 | Davis Jennifer L. · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | WADDELL FREDERICK H · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | Hart Brett J · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | RAPP EDWARD J · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | AUSTIN ROXANNE S · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | FALK THOMAS J · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | MEYER MELODY B · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | Quaggin Susan E · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | FREYMAN THOMAS C · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | BURNSIDE WILLIAM H.L. · director | A-Award | 1,118 | $0.00 |
| May 12, 2026 | Roberts Rebecca B · director | A-Award | 1,118 | $0.00 |
| Apr 2, 2026 | Alpern Robert J · director | A-Award | 35 | $217 |
| Apr 2, 2026 | Quaggin Susan E · director | A-Award | 71 | $217 |
| Apr 2, 2026 | RAPP EDWARD J · director | A-Award | 155 | $217 |
| Mar 11, 2026 | Purdue David Ryan · officer: SVP, Controller | F-InKind | 2,108 | $232 |
| Mar 6, 2026 | Crum Demetris D · officer: EVP, CHIEF HR OFFICER | F-InKind | 1,594 | $232 |
| Mar 6, 2026 | Purdue David Ryan · officer: SVP, Controller | Sale | 5,230 | $234 |
| Mar 3, 2026 | Stewart Jeffrey Ryan · officer: EVP, CHIEF COMMERCIAL OFFICER | F-InKind | 23,812 | $232 |
| Mar 3, 2026 | Michael Robert A. · director, officer: CHAIRMAN OF THE BOARD AND CEO | F-InKind | 36,523 | $232 |
| Mar 3, 2026 | SALEKI-GERHARDT AZITA · officer: EVP, CHIEF OPERATIONS OFFICER | F-InKind | 16,309 | $232 |
| Mar 3, 2026 | Reents Scott T · officer: EVP, CHIEF FINANCIAL OFFICER | F-InKind | 21,638 | $232 |
| Mar 3, 2026 | Siatis Perry C · officer: EVP, GC AND SECRETARY | Sale | 2,600 | $235 |
| Mar 3, 2026 | Siatis Perry C · officer: EVP, GC AND SECRETARY | F-InKind | 14,850 | $232 |
| Mar 3, 2026 | Siatis Perry C · officer: EVP, GC AND SECRETARY | Sale | 10,291 | $235 |
| Mar 3, 2026 | Thakkar Roopal · officer: EVP, R&D and CSO | F-InKind | 8,037 | $232 |
| Mar 3, 2026 | Donoghoe Nicholas · officer: EVP, CHIEF BUS/STRAT OFFICER | F-InKind | 12,874 | $232 |
Institutional positioning
13F filings over the trailing two quarters
New 503Increased 3633Reduced 3286Sold out 123
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 150,749,625 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 149,488,412 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 115,396,098 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 114,880,324 | May 15, 2026 |
| STATE STREET CORP | Increased | 82,596,748 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 81,217,516 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 56,741,691 | May 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 49,523,078 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 48,477,996 | Aug 13, 2026 |
| JPMORGAN CHASE & CO | Reduced | 47,862,796 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 46,998,433 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 46,737,581 | May 15, 2026 |
| MORGAN STANLEY | Increased | 38,901,001 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 38,016,774 | May 15, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 31,254,786 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026